
Infant acute lymphoblastic #leukemia (#ALL) is heavily driven by #KMT2A gene rearrangements, leading to high relapse rates. Dr. Lisa Niswander (@RoswellPark) discusses a new approach combining #CARTCell therapy with targeted #menin inhibitors. Watch here! youtu.be/YunIWpp1eYU?si=NDSF…

















